OCSL

Oaktree Specialty Lending Corp

Add to Watchlist

Advanced Chart

14.040

-0.13(-0.917%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

14.230

Open

14.230

VWAP

Vol

516.97K

Mkt Cap

1.24B

Low

13.9347

Amount

EV/EBITDA(TTM)

19.52

Total Shares

81.40M

2.59B

EV/OCF(TTM)

10.71

P/S(TTM)

9.92

Oaktree Specialty Lending Corporation is a specialty finance company. The Company is engaged in providing customized one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company’s investment objective is to generate current income and capital appreciation by providing companies with financing solutions, including first and second lien loans, unsecured and mezzanine loans, and preferred equity. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Its portfolio may also include certain structured finance and other non-traditional structures. Its portfolio of investments includes application software, multi-sector holdings, data processing and outsourced services, pharmaceuticals, biotechnology, health care services, specialized finance, and others. The Company is externally managed by Oaktree Fund Advisors, LLC (Oaktree).

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q2

FY2025Q1

79.14M

-16.67%

0.447

-17.14%

84.43M

-10.21%

0.490

-12.47%

91.93M

-6.18%

0.542

-4.84%

Estimates Revision

The market is revising No Change the revenue expectations for Oaktree Specialty Lending Corporation (OCSL) for FY2024, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -2.50%.

Revenue Estimates for FY2024

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2024

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-2.50%

In Past 3 Month

4 Analyst Rating

-4.70% Downside

Wall Street analysts forecast OCSL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for OCSL is 13.38 USD with a low forecast of 13.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

4 Hold

0 Sell

Hold

-4.70% Downside

Current: 14.040

Low

13.00

Averages

13.38

High

14.00

-4.70% Downside

Current: 14.040

Low

13.00

Averages

13.38

High

14.00

B. Riley

Sean-Paul Adams

Sell

Neutral

upgrade

$15 -> $14

2025-05-13

Reason

B. Riley

Sean-Paul Adams

Price Target

$15 -> $14

2025-05-13

upgrade

Sell

Neutral

Reason

B. Riley analyst Sean-Paul Adams upgraded Oaktree Specialty Lending to Neutral from Sell with a price target of $14, down from $15, following a transfer in coverage. The firm transferred coverage of the business development companies. While credit trends remain broadly stable across most portfolios and dividend coverage "appears supported," tighter spreads, lower prepayment activity, and "tapered" forecasts of origination activity are weighing modestly on near-term earnings visibility, the analyst tells investors in a research note. The firm's Buy ratings reflect "differentiated" origination strategies, favorable returns on equity, and stable-to-improving portfolio metrics. Riley names Trinity Capital (TRIN), Sixth Street Specialty Lending (TSLX), and Blue Owl Capital (OBDC) its top BDC ideas.

Keefe, Bruyette & Woods

Paul Johnson

Hold

Maintains

$17 → $15

2025-04-08

Reason

Keefe, Bruyette & Woods

Paul Johnson

Price Target

$17 → $15

2025-04-08

Maintains

Hold

Reason

Keefe Bruyette lowered the firm's price target on Oaktree Specialty Lending to $15 from $16.50 and keeps a Market Perform rating on the shares.

Oppenheimer

Mitchel Penn

Hold

Maintains

$18

2024-11-22

Reason

Oppenheimer

Mitchel Penn

Price Target

$18

2024-11-22

Maintains

Hold

Reason

JP Morgan

Melissa Wedel

Buy

Hold

Downgrades

$17 → $15

2024-11-20

Reason

JP Morgan

Melissa Wedel

Price Target

$17 → $15

2024-11-20

Downgrades

Buy

Hold

Reason

JPMorgan analyst Melissa Wedel downgraded Oaktree Specialty Lending to Neutral from Overweight with a price target of $15, down from $17, following the Q4 report. The company's net asset value was modestly lower on additional portfolios marks and realized losses, and as Oaktree Specialty achieved dividend coverage through net interest income after waiving partial incentive fees for the second sequential quarter, the analyst tells investors in a research note. The firm reduced assumed portfolio yield as a function of tighter spreads and lower expected base rates. A re-rating of shares is unlikely without better line of sight to net asset value stability and full dividend coverage through net interest income in light of lower expected base rates, contends JPMorgan.

B. Riley Securities

Bryce Rowe

Hold

Maintains

$17 → $15

2024-11-20

Reason

B. Riley Securities

Bryce Rowe

Price Target

$17 → $15

2024-11-20

Maintains

Hold

Reason

Keefe, Bruyette & Woods

Paul Johnson

Hold

Maintains

$18 → $17

2024-11-20

Reason

Keefe, Bruyette & Woods

Paul Johnson

Price Target

$18 → $17

2024-11-20

Maintains

Hold

Reason

Keefe Bruyette analyst Paul Johnson lowered the firm's price target on Oaktree Specialty Lending to $17 from $18 and keeps a Market Perform rating on the shares. The firm says that while non-accruals declined slightly, credit issues have persisted for Oaktree, and this quarter was not an improvement. The analyst reduced estimates due to a lower base rate projection and portfolio yield compression. Keefe believes the company's dividend is at risk. Despite the positive fee waiver and prior base fee reduction, Oaktree's net interest income is currently below the dividend, and the dividend seems unsustainable, the analyst tells investors in a research note.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Oaktree Specialty Lending Corp (OCSL.O) is 6.17, compared to its 5-year average forward P/E of 8.80. For a more detailed relative valuation and DCF analysis to assess Oaktree Specialty Lending Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

8.80

Current PE

6.17

Overvalued PE

10.41

Undervalued PE

7.20

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

4.14

Current PS

3.22

Overvalued PS

5.01

Undervalued PS

3.27